EM8-31548-56487 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-16
Dose 1 — Pfizer-BioNTech
2021-05-07
Dose 2 — Pfizer-BioNTech
2021-11-29
Registered in v-safe
2021-11-29
Dose 3 — Pfizer-BioNTech
2021-11-29
Survey response — day 0, dose 3
MedDRA: Pregnancy — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: I am pregnant

MedDRA releases: 2024-11 · check-in free text available
2021-11-30
Survey response — days 1–6 daily, dose 3
MedDRA: Chest pain — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chest pain

MedDRA releases: 2024-11 · check-in free text available
2021-12-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · None

Adult check-in
2021-12-02
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-12-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-16	Pfizer-BioNTech	No
2	2021-05-07	Pfizer-BioNTech	No
3	2021-11-29	Pfizer-BioNTech	No

Free text

Release 10 — day 0, dose 3

2021-11-29

Systemic reaction (other): I am pregnant

Release 10 — days 1–6 daily, dose 3

2021-11-30

Systemic reaction (other): Chest pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Chest pain	·	·	✓
SRO	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release